We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.57%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$86.2B
AUM Growth
-$3.13B
(-3.5%)
Cap. Flow
+$224M
Cap. Flow
% of AUM
0.26%
Top 10 Holdings %
Top 10 Hldgs %
24.96%
Holding
4,488
New
66
Increased
2,157
Reduced
1,702
Closed
141
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Kenvue
KVUE
|
+$72.5M |
| 2 |
iShares Russell 1000 ETF
IWB
|
+$54.4M |
| 3 |
Blackstone
BX
|
+$44M |
| 4 |
Airbnb
ABNB
|
+$37.4M |
| 5 |
Everest Group
EG
|
+$30.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$57.8M |
| 2 |
LSI
Life Storage, Inc.
LSI
|
+$39.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$23.8M |
| 4 |
iShares Global Infrastructure ETF
IGF
|
+$19.2M |
| 5 |
PDCE
PDC Energy, Inc.
PDCE
|
+$18.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.73% |
| 2 | Healthcare | 12.76% |
| 3 | Financials | 12.67% |
| 4 | Consumer Discretionary | 11.16% |
| 5 | Industrials | 9.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AXA
2176
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $1.03M | ﹤0.01% |
34,490
+629
| +2% | +$18.7K |
|
2177
Editas Medicine
EDIT
$442M
| $1.03M | ﹤0.01% |
131,419
+14,360
| +12% | +$123K |
|
2178
Amplitude
AMPL
$1.41B
| $1.02M | ﹤0.01% |
88,549
+1,477
| +2% | +$17.1K |
|
2179
FIGS
FIGS
$2.37B
| $1.02M | ﹤0.01% |
173,640
+915
| +0.5% | +$6.09K |
|
2180
Napco Security Technologies
NSSC
$1.48B
| $1.02M | ﹤0.01% |
46,023
+1,810
| +4% | +$54.9K |
|
2181
HCI Group
HCI
$2.41B
| $1.02M | ﹤0.01% |
18,853
-1,198
| -6% | -$68.1K |
|
2182
Lemonade
LMND
$4.1B
| $1.02M | ﹤0.01% |
87,437
-1,750
| -2% | -$28.1K |
|
2183
argenx
ARGX
$54.1B
| $1.01M | ﹤0.01% |
2,061
-327
| -14% | -$160K |
|
2184
Kura Oncology
KURA
$850M
| $1.01M | ﹤0.01% |
110,876
+5,260
| +5% | +$53.4K |
|
2185
Travere Therapeutics
TVTX
$5.78B
| $1.01M | ﹤0.01% |
113,059
-384
| -0.3% | -$5.42K |
|
2186
Baidu
BIDU
$37.2B
| $1.01M | ﹤0.01% |
7,487
+8
| +0.1% | +$1.12K |
|
2187
Intapp
INTA
$2.91B
| $1.01M | ﹤0.01% |
29,987
+8,344
| +39% | +$305K |
|
2188
Bank First Corp
BFC
$1.7B
| $1M | ﹤0.01% |
13,016
+241
| +2% | +$19.7K |
|
2189
BP
BP
$107B
| $1M | ﹤0.01% |
25,905
+345
| +1% | +$12.8K |
|
2190
Fomento Económico Mexicano
FMX
$41.7B
| $1M | ﹤0.01% |
9,187
-62
| -0.7% | -$6.88K |
|
|
CTEV
2191
Claritev Corp
CTEV
$556M
| $1,000K | ﹤0.01% |
14,876
+165
| +1% | +$12.2K |
|
2192
RxSight
RXST
$260M
| $999K | ﹤0.01% |
35,830
+1,148
| +3% | +$34.2K |
|
2193
Astronics
ATRO
$3.84B
| $997K | ﹤0.01% |
75,428
+1,254
| +2% | +$18.8K |
|
2194
Forrester Research
FORR
$224M
| $997K | ﹤0.01% |
34,487
+741
| +2% | +$22.8K |
|
2195
Community Health Systems
CYH
$423M
| $995K | ﹤0.01% |
343,014
+3,431
| +1% | +$12.7K |
|
2196
Smith & Wesson
SWBI
$637M
| $994K | ﹤0.01% |
76,987
+2,464
| +3% | +$30.8K |
|
|
HAPN
2197
Happen Inc
HAPN
$2.24B
| $989K | ﹤0.01% |
162,158
+145
| +0.1% | +$1.13K |
|
2198
Canadian National Railway
CNI
$76.6B
| $987K | ﹤0.01% |
9,113
+246
| +3% | +$28.2K |
|
2199
Bladex Inc
BLX
$2.14B
| $986K | ﹤0.01% |
46,498
+2,089
| +5% | +$48.2K |
|
2200
Phibro Animal Health
PAHC
$1.39B
| $985K | ﹤0.01% |
77,171
+2,506
| +3% | +$35.5K |
|
Similar funds
VAM
RhumbLine Advisers's Q3 2023 Portfolio in Review
As of Q3 2023, RhumbLine Advisers held 4,488 positions worth $86.2B, down 3.5% from $89.3B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q3 2023: portfolio turnover was 4.6%. RhumbLine Advisers opened 66 new positions and exited 141, leaving the 4,488-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- RhumbLine Advisers's largest Q3 2023 buy was Kenvue: 3,131,012 shares worth $62.9M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q3 2023, an estimated $54.4M increase.
- RhumbLine Advisers's biggest Q3 2023 reduction was Johnson & Johnson, cutting an estimated $57.8M.
- RhumbLine Advisers fully exited Life Storage, Inc. in Q3 2023, selling an estimated $39.6M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $86.2B portfolio in Q3 2023.
- RhumbLine Advisers opened 66 new positions and closed 141 in Q3 2023.
- RhumbLine Advisers's portfolio value fell 3.5% quarter-over-quarter to $86.2B.
Based on RhumbLine Advisers's 13F filing for Q3 2023, filed 9 Nov 2023.